Portincasa, Piero http://orcid.org/0000-0001-5359-1471
Frühbeck, Gema http://orcid.org/0000-0002-8305-7154
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/00745)
Universidad de Navarra
Article History
Accepted: 27 July 2023
First Online: 4 August 2023
Declarations
:
: Not applicable.
: Not applicable.
: GF declares research grants paid to the Institution from the Spanish Institute of Health ISCIII and payment of honoraria for lectures from Novo Nordisk as Member of the OPEN Spain Initiative as well as payment or honoraria for attendance to Advisory Boards from Lilly. PP declares no conflict of interest.